secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2026-06-05T20:30:36+00:00
Accession:  0001104659-26-071000
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte regains Nasdaq minimum bid price compliance as of June 5, 2026
-----------------------------------------------------------------------

- Nasdaq notified Humacyte that closing bid price was below $1.00 for 30 consecutive days as of May 1, 2026.
- Company had until November 2, 2026 to regain compliance by closing at $1.00+ for 10 consecutive days.
- On June 5, 2026, Nasdaq confirmed compliance and considers the matter closed.
- Common stock (HUMA) and warrants (HUMAW) remain listed on The Nasdaq Global Select Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465926071000/0001104659-26-071000-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465926071000/tm2616944d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-071000

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer